𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The spectrum of chronic lymphoproliferative disorders in Hong Kong. A prospective study

✍ Scribed by Chan, L C; Lam, C K; Yeung, T C; Chu, R W; Ng, M; Chow, E Y D; Wickham, N; Matutes, E

Book ID
110053663
Publisher
Nature Publishing Group
Year
1997
Tongue
English
Weight
94 KB
Volume
11
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of alemtuzumab in chronic
Phase II study of alemtuzumab in chronic lymphoproliferative disorders
✍ Alessandra Ferrajoli; Susan M. O'Brien; Jorge E. Cortes; Francis J. Giles; Debor πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

## Abstract ## BACKGROUND Pilot studies showed that alemtuzumab is active in lymphoproliferative disorders. The authors conducted a Phase II trial to evaluate the efficacy and safety of alemtuzumab in advanced or refractory chronic lymphoproliferative disorders. ## METHODS Seventy‐eight patients